J. B. Chemicals & Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
J. B. Chemicals & Pharmaceuticals has a total shareholder equity of ₹32.1B and total debt of ₹816.4M, which brings its debt-to-equity ratio to 2.5%. Its total assets and total liabilities are ₹40.3B and ₹8.2B respectively. J. B. Chemicals & Pharmaceuticals's EBIT is ₹8.1B making its interest coverage ratio 33.1. It has cash and short-term investments of ₹4.2B.
Key information
2.5%
Debt to equity ratio
₹816.40m
Debt
| Interest coverage ratio | 33.1x |
| Cash | ₹4.17b |
| Equity | ₹32.12b |
| Total liabilities | ₹8.17b |
| Total assets | ₹40.29b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 506943's short term assets (₹19.1B) exceed its short term liabilities (₹6.2B).
Long Term Liabilities: 506943's short term assets (₹19.1B) exceed its long term liabilities (₹2.0B).
Debt to Equity History and Analysis
Debt Level: 506943 has more cash than its total debt.
Reducing Debt: 506943's debt to equity ratio has reduced from 3% to 2.5% over the past 5 years.
Debt Coverage: 506943's debt is well covered by operating cash flow (912.6%).
Interest Coverage: 506943's interest payments on its debt are well covered by EBIT (33.1x coverage).